The lipid platform increases the activity of STING agonists to synergize checkpoint blockade therapy against melanoma

Kesang Li(State Key Laboratory of Oncogene and Related Genes), Jinyan Wang(Ningbo No. 2 Hospital), Yingyi Ye(University of Chinese Academy of Sciences), Li Zhang(State Forestry and Grassland Administration), Xiaolu Wang(University of Chinese Academy of Sciences), Ting Jiao(Shanghai Jiao Tong University), Qian Sha(Shenzhen Maternity and Child Healthcare Hospital), Liqin Liu(Xinjiang Agricultural University)
Biomaterials Science
November 4, 2020
Cited by 47


Related Papers